Loan & DebtJun 15, 2026, 05:26 PM
NeoGenomics Proposes $275M Convertible Senior Notes Offering
AI Summary
NeoGenomics, Inc. announced the commencement of a proposed offering of $275 million in convertible senior notes due 2032 to qualified institutional buyers. The company may also grant an option for an additional $41.25 million in notes. Proceeds are intended for capped call transactions, repurchasing existing 0.25% convertible senior notes due 2028, and repurchasing up to $25 million of its common stock. The offering is subject to market conditions.
Key Highlights
- NeoGenomics commences proposed offering of $275 million convertible senior notes due 2032.
- Company may grant option to purchase an additional $41.25 million in notes.
- Notes will be senior, unsecured obligations maturing July 1, 2032.
- Proceeds to fund capped call transactions, repurchase existing notes and common stock.
- Plans to repurchase a portion of existing 0.25% convertible senior notes due 2028.
- May repurchase up to $25 million of outstanding common stock.
Price Impact
More from NEO